Gara Jalqabaatti › Dukkana Tract Biliary › California › Los Angeles
Qorannoo klinikaalii Dukkana Tract Biliary Los Angeles, CA keessatti
Qorannoo 11 Dukkana Tract Biliary f Los Angeles fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Los Angeles
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Namoota walitti qabaa jiraSadarkaa 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Namoota walitti qabaa jiraSadarkaa 1/2
- UCLA ( Site 0317), Los Angeles
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Namoota walitti qabaa jiraSadarkaa 2
- Research Site, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Namoota walitti qabaa jiraSadarkaa 1/2
- Avenzo Therapeutics Recruiting Site, Los Angeles
- Avenzo Therapeutics Recruiting Site, Los Angeles
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Los Angeles
- Research Site, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Namoota walitti qabaa jiraSadarkaa 1/2
- Los Angeles Cancer Network, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Cedars-Sinai Medical Center, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Namoota walitti qabaa jira
- Cedars-Sinai Medical Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Southern California, Los Angeles
Qorannoo Dukkana Tract Biliary magaalota biroo keessatti
- Houston, TXQorannoo 18
- Boston, MAQorannoo 11
- New York City, NYQorannoo 10
- Nashville, TNQorannoo 9
- Baltimore, MDQorannoo 8
- San Antonio, TXQorannoo 8
- Washington, DCQorannoo 7
- Pittsburgh, PAQorannoo 7
- Arlington, VAQorannoo 7
- Madison, WIQorannoo 6
- Columbus, OHQorannoo 6
- Cleveland, OHQorannoo 6
Qorannoo biroo Los Angeles keessatti
- Kansara Qara'a Non-Small CellQorannoo 87
- Saree (Gosoota Hunda)Qorannoo 74
- Saree OljooQorannoo 73
- Kansarii ProstateQorannoo 61
- Kansarii ColorectalQorannoo 59
- Kansara MetastatikiiQorannoo 57
- Kansarii OvariiQorannoo 50
- Dhibee QaraQorannoo 45
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 42
- Kansarii PancreasQorannoo 35
- Kansa EndometiriyaaliiQorannoo 34
- MelanomaQorannoo 34
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.